MISTX Performance — BNY Mellon Short-Term U.S. Government Securities Fund, Investor Shares
Data updated: 2025-07-29
MISTX returned +4.80% over one year to May 2025. Annualised returns are +2.72% over 3 years and +0.94% over 5 years. The fund trailed its Short-Term Securitized Bond category average: $100 invested three years ago grew to $108, against $114 for the category, and to $105 over one year, against $107. Volatility over the past three years was 1.68% a year. In the 12 months to May 2025 the fund lost a net $29.5M, and assets reached $65.73M.
MISTX Growth of $100
What $100 invested in BNY Mellon Short-Term U.S. Government Securities Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Securitized Bond category average over the same months.
| Period | MISTX | Category average |
|---|---|---|
| 1 year (Jun 2024 – May 2025) | $105 | $107 |
| 3 years (Jun 2022 – May 2025) | $108 | $114 |
| 5 years (Jun 2020 – May 2025) | $105 | $120 |
| Since data start (Sep 2019 – May 2025) | $107 | $119 |
MISTX Trailing Returns
Total returns to May 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +4.80% |
| 3 years (annualised) | +2.72% |
| 5 years (annualised) | +0.94% |
MISTX Annual Returns
Calendar-year total returns of BNY Mellon Short-Term U.S. Government Securities Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–May) | +1.77% |
| 2024 | +3.98% |
| 2023 | +3.82% |
| 2022 | −3.67% |
| 2021 | −1.19% |
| 2020 | +2.59% |
| 2019 (Sep–Dec) | +0.14% |
MISTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.3% | +0.6% | +0.4% | +0.6% | −0.1% | — | — | — | — | — | — | — |
| 2024 | +0.4% | −0.1% | +0.3% | −0.1% | +0.5% | +0.5% | +0.9% | +0.9% | +0.6% | −0.3% | +0.3% | +0.1% |
| 2023 | +0.7% | −0.5% | +1.1% | +0.2% | −0.2% | −0.2% | +0.3% | +0.4% | −0.2% | +0.3% | +1.0% | +1.1% |
| 2022 | −0.6% | −0.4% | −1.3% | −0.6% | +0.5% | −0.4% | +0.2% | −0.7% | −0.9% | −0.3% | +0.5% | +0.2% |
| 2021 | 0.0% | −0.2% | 0.0% | 0.0% | 0.0% | −0.2% | +0.2% | −0.1% | −0.1% | −0.4% | 0.0% | −0.2% |
| 2020 | +0.7% | +0.8% | +0.7% | +0.2% | 0.0% | +0.1% | 0.0% | 0.0% | −0.1% | −0.1% | 0.0% | +0.1% |
| 2019 | — | — | — | — | — | — | — | — | 0.0% | +0.2% | 0.0% | 0.0% |
MISTX Risk
Risk measures from monthly returns over Jun 2022 – May 2025.
- 3-year volatility (annualised): 1.68%
- 3-year Sharpe ratio: -1.06 (vs 4.5% risk-free rate)
- Best month: +1.13% (Mar 2023)
- Worst month: −0.86% (Sep 2022)
MISTX Fund Flows
Monthly money in and out of BNY Mellon Short-Term U.S. Government Securities Fund, from SEC Form N-PORT.
- 12-month net flow: −$29.5M
- 12-month gross sales (incl. reinvestments): $15.4M
- Sales ÷ redemptions: 0.34×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2025 | $1.6M | $7.2M | −$5.6M |
| Apr 2025 | $4.6M | $1.7M | $2.9M |
| Mar 2025 | $397K | $3.7M | −$3.3M |
| Feb 2025 | $3.1M | $1.6M | $1.5M |
| Jan 2025 | $990K | $2.9M | −$1.9M |
| Dec 2024 | $383K | $2.4M | −$2.0M |
| Nov 2024 | $586K | $7.3M | −$6.7M |
| Oct 2024 | $279K | $2.0M | −$1.7M |
| Sep 2024 | $342K | $2.1M | −$1.8M |
| Aug 2024 | $680K | $4.3M | −$3.6M |
| Jul 2024 | $1.9M | $3.7M | −$1.8M |
| Jun 2024 | $496K | $6.0M | −$5.5M |
MISTX Assets Under Management
Net assets of BNY Mellon Short-Term U.S. Government Securities Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-05-31 | $65.73M |
| 2025-02-28 | $71.59M |
| 2024-11-30 | $73.71M |
| 2024-08-31 | $83.93M |
| 2024-05-31 | $93.52M |
| 2024-02-29 | $104.58M |
| 2023-11-30 | $127.61M |
| 2023-08-31 | $126.57M |
| 2023-05-31 | $146.64M |
| 2023-02-28 | $172.38M |
| 2022-11-30 | $186.56M |
| 2022-08-31 | $176.90M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.